Ticker LaunchIPO · AAPG
Ascentage Pharma Group International
Ascentage Pharma Group International (AAPG) priced its initial public offering on Jan 24, 2025 at $17.25 per ADS, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $5.93B. J.P. Morgan was lead-left underwriter, joined by Citigroup. JunHe advised the company and Commerce & Finance advised the underwriters.
- Status
- IPO
- Ticker
- AAPG
- Exchange
- Nasdaq Global Market
- Priced
- Jan 24, 2025
- IPO price
- $17.25 per ADS
- Market cap at IPO price
- $5.93B
- First filed
- Dec 27, 2024
- Underwriters
- J.P. Morgan and Citigroup
- Company counsel
- JunHe
- Underwriters' counsel
- Commerce & Finance
- Sector
- Biotech & pharma
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (F-1) first filed Dec 27, 2024
- Latest amendment Jan 21, 2025
- Final prospectus (424B4) Jan 24, 2025
- All filings on EDGAR CIK 2023311
Other Biotech & pharma IPOs in 2025
- Anbio BiotechnologyNNNN · Feb 19, 2025
- Aardvark Therapeutics, Inc.AARD · Feb 13, 2025 · $94.2M
- Sionna Therapeutics, Inc.SION · Feb 7, 2025 · $190.6M
- Maze Therapeutics, Inc.MAZE · Jan 31, 2025 · $140M
- Metsera, Inc.MTSR · Jan 31, 2025 · $275M
- Zhengye Biotechnology Holding LtdZYBT · Jan 7, 2025 · $6M